Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Dynamics of human complement-mediated killing of Klebsiella pneumoniae.

Nypaver CM, Thornton MM, Yin SM, Bracho DO, Nelson PW, Jones AE, Bortz DM, Younger JG.

Am J Respir Cell Mol Biol. 2010 Nov;43(5):585-90. doi: 10.1165/rcmb.2009-0292OC. Epub 2009 Dec 11.

2.
3.
4.

Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.

Lagergård T, Frisk A, Purvèn M, Nilsson LA.

Microb Pathog. 1995 Jan;18(1):37-51.

PMID:
7783597
5.

Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.

Namavar F, Kaan JA, Verweij-van Vught AM, Vel WA, Bal M, Kester AD, MacLaren DM.

Eur J Clin Microbiol. 1986 Jun;5(3):324-9.

PMID:
3527702
6.

Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.

Yang KD, Bathras JM, Shigeoka AO, James J, Pincus SH, Hill HR.

J Infect Dis. 1989 Apr;159(4):701-7.

PMID:
2494269
7.

Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.

Albertí S, Alvarez D, Merino S, Casado MT, Vivanco F, Tomás JM, Benedí VJ.

Infect Immun. 1996 Nov;64(11):4726-32.

8.

Complement resistance mechanisms of Klebsiella pneumoniae.

Doorduijn DJ, Rooijakkers SH, van Schaik W, Bardoel BW.

Immunobiology. 2016 Oct;221(10):1102-9. doi: 10.1016/j.imbio.2016.06.014. Epub 2016 Jun 16. Review.

9.

Increasing opsonizing and killing effect of serum from patients with recurrent K1 Klebsiella pneumoniae liver abscess.

Yeh FC, Yeh KM, Siu LK, Fung CP, Yang YS, Lin JC, Chang FY.

J Microbiol Immunol Infect. 2012 Apr;45(2):141-6. doi: 10.1016/j.jmii.2011.12.006. Epub 2012 Mar 21.

10.
11.
12.

Influence of lipopolysaccharide chemotype on the interaction between Klebsiella pneumoniae and human polymorphonuclear leucocytes.

Williams P, Ciurana B, Camprubi S, Tomas JM.

FEMS Microbiol Lett. 1990 Jun 1;57(3):305-9.

PMID:
1698690
13.

Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.

Hair PS, Echague CG, Rohn RD, Krishna NK, Nyalwidhe JO, Cunnion KM.

J Transl Med. 2012 Mar 5;10:35. doi: 10.1186/1479-5876-10-35.

14.

Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.

Verbrugh HA, Peterson PK, Nguyen BY, Sisson SP, Kim Y.

J Immunol. 1982 Oct;129(4):1681-7.

PMID:
7108223
15.

Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing.

Merino S, Camprubí S, Albertí S, Benedí VJ, Tomás JM.

Infect Immun. 1992 Jun;60(6):2529-35.

16.

Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination.

Gomez-Lus ML, Giménez MJ, Vázquez JA, Aguilar L, Anta L, Berrón S, Laguna B, Prieto J.

Infection. 2003 Jan;31(1):51-4.

PMID:
12590334
19.

Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils.

Dalia AB, Standish AJ, Weiser JN.

Infect Immun. 2010 May;78(5):2108-16. doi: 10.1128/IAI.01125-09. Epub 2010 Feb 16.

20.

Susceptibility of Helicobacter pylori to the bactericidal activity of human serum.

Gonzalez-Valencia G, Perez-Perez GI, Washburn RG, Blaser MJ.

Helicobacter. 1996 Mar;1(1):28-33.

PMID:
9398910

Supplemental Content

Support Center